Clinical Trial Update: Simvastatin add-on Treatment to Standard Antidepressant Therapy in Patients With Comorbid Obesity and Major Depression [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating simvastatin added to standard antidepressant therapy in adults with major depressive disorder and obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Obesity

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Depressive Disorder, Major, Obesity | Phase 2 | Status: COMPLETED